Tue. 14 May 2024, 8:29am ET
Benzinga
Earnings, Earnings Beats, News
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.42) by 40.48 percent. This is a 16.67 percent increase over losses of $(0.30) per share from the same period last year.